This study is testing a drug called ION775 to see how safe and effective it is for people with high triglycerides (hypertriglyceridemia) or very high triglycerides (severe hypertriglyceridemia). ION775 is given as a shot under the skin. To join, you must be an adult with fasting triglyceride levels of 350 mg/dL or higher, or 500 mg/dL or higher for severe cases. You should also be taking your usual medications for high cholesterol. The main goal is to see how much ION775 changes your fasting triglyceride levels after six months. The study is currently recruiting 72 participants, but its overall status is unclear.

Study design

This is an open-label study, meaning you and your doctors will know you are receiving ION775. It plans to enroll 72 participants.

What's involved

You would participate in a screening period lasting 4-6 weeks, followed by a 6-month treatment period.

Compensation

Not stated in the trial record.

Follow-up

After the 6-month treatment period, there is a 6-month follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.